160 related articles for article (PubMed ID: 29306668)
1. A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
Li K; O'Brien R; Lutz M; Luo S;
Alzheimers Dement; 2018 May; 14(5):644-651. PubMed ID: 29306668
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
4. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM;
JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480
[TBL] [Abstract][Full Text] [Related]
5. Predicting Progression From Mild Cognitive Impairment to Alzheimer's Disease Using Autoregressive Modelling of Longitudinal and Multimodal Biomarkers.
Minhas S; Khanum A; Riaz F; Khan SA; Alvi A
IEEE J Biomed Health Inform; 2018 May; 22(3):818-825. PubMed ID: 28534796
[TBL] [Abstract][Full Text] [Related]
6. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
[TBL] [Abstract][Full Text] [Related]
7. Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Martinez-Torteya A; Gomez-Rueda H; Trevino V; Farber J; Tamez-Pena J; For The Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2018; 15(8):751-763. PubMed ID: 29422002
[TBL] [Abstract][Full Text] [Related]
8. Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?
Rabelo AG; Teixeira CV; Magalhães TN; Carletti-Cassani AFM; Amato Filho AC; Joaquim HP; Talib LL; Forlenza O; Ribeiro PA; Secolin R; Lopes-Cendes I; Cendes F; Balthazar ML
Neuroradiol J; 2017 Oct; 30(5):477-485. PubMed ID: 28714354
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
10. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
11. Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data.
Li K; Luo S
Stat Med; 2019 Oct; 38(24):4804-4818. PubMed ID: 31386218
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database.
Ben Bouallègue F; Vauchot F; Mariano-Goulart D; Payoux P
Brain Imaging Behav; 2019 Feb; 13(1):111-125. PubMed ID: 29427064
[TBL] [Abstract][Full Text] [Related]
13. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
[TBL] [Abstract][Full Text] [Related]
14. Instance-Based Representation Using Multiple Kernel Learning for Predicting Conversion to Alzheimer Disease.
Collazos-Huertas D; Cárdenas-Peña D; Castellanos-Dominguez G
Int J Neural Syst; 2019 Mar; 29(2):1850042. PubMed ID: 30415632
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal survival analysis and two-group comparison for predicting the progression of mild cognitive impairment to Alzheimer's disease.
Platero C; Tobar MC
J Neurosci Methods; 2020 Jul; 341():108698. PubMed ID: 32534272
[TBL] [Abstract][Full Text] [Related]
16. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
[TBL] [Abstract][Full Text] [Related]
17. Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
Iwatsubo T; Iwata A; Suzuki K; Ihara R; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; ; Sun CK; Beckett LA; Petersen RC; Weiner MW; Aisen PS; Donohue MC;
Alzheimers Dement; 2018 Aug; 14(8):1077-1087. PubMed ID: 29753531
[TBL] [Abstract][Full Text] [Related]
18. Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.
Fowler ME; Triebel KL; Cutter GR; Schneider LS; Kennedy RE;
J Alzheimers Dis; 2020; 76(2):691-701. PubMed ID: 32538844
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
[TBL] [Abstract][Full Text] [Related]
20. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT;
J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
